OPS
MRTX

Orion Portfolio Solutions’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Orion Portfolio Solutions’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-29,261
Closed -$1.27M – 1774
2023
Q3 		$1.27M Buy
29,261
+6,944
+31% +$248K 0.02% 817
2023
Q2 		$806K Sell
22,317
-729
-3% -$30K 0.01% 1035
2023
Q1 		$857K Buy
+23,046
New +$1.04M 0.01% 942
2020
Q1 		– Sell
-1
Closed – – 2392
2019
Q4 		$0 Buy
+1
New +$96 ﹤0.01% 1985

Other funds holding MRTX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SS
Simplicity Solutions Minneapolis, Minnesota $3.66B AUM 23.51% 1-Year Est. Return
B
Braslyn New Providence, Bahamas $7.81M AUM 338.68% 1-Year Est. Return

Orion Portfolio Solutions's MRTX Position: Q4 2023 in Review

Orion Portfolio Solutions sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q4 2023, closing a stake of 29,261 shares — an estimated $1.27M sold.

Orion Portfolio Solutions first reported a position in MRTX in Q4 2019 and held it in 4 quarters. The position peaked at $1.27M in Q3 2023. 217 funds tracked by Wall St. Rank hold MRTX as of Q4 2023.

  • Orion Portfolio Solutions reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Orion Portfolio Solutions sold 29,261 Mirati Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $1.27M.
  • Orion Portfolio Solutions first reported a position in Mirati Therapeutics, Inc. Common Stock in Q4 2019 and held it in 4 quarters.
  • Orion Portfolio Solutions's Mirati Therapeutics, Inc. Common Stock position peaked at $1.27M in Q3 2023.
  • 217 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Orion Portfolio Solutions's 13F filing for Q4 2023, filed 9 Feb 2024.